Want to see PRLD full AI Analyst Report?

Prelude Therapeutics (PRLD) Revenue

193 Followers

Prelude Therapeutics Revenue

Prelude Therapeutics had a revenue of 5.70M in the quarter ending Jun 30, 2026, with 24.54%. This bring the company's revenue in the last twelve months to 22.42M, Decreased 34.11%. In the fiscal year ending Dec 31, 2025, Prelude Therapeutics had annual revenue of 12.14M with 73.43% growth.

Revenue (ttm)

22.42M

Revenue Growth

220.34%

P/S Ratio

34.84

Revenue/Employee

$153,671

Employees

Market Cap

$422.96M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	12.14M	5.14M	+73.43%
Dec 31, 2024	7.00M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―